Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Antibody EngineeringAntibody Engineering
Not Confirmed
Not Confirmed
15-19 December, 2024
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Not Confirmed
Not Confirmed
03-05 January, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Antibody EngineeringAntibody Engineering
Industry Trade Show
Not Confirmed
15-19 December, 2024
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Industry Trade Show
Not Confirmed
03-05 January, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions
14 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aileron-therapeutics-reports-third-quarter-2024-financial-results-and-recent-business-highlights-302306387.html
13 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aileron-therapeutics-announces-positive-topline-data-from-cohort-2-of-the-phase-1b-clinical-trial-of-lti-03-in-idiopathic-pulmonary-fibrosis-ipf-302303568.html
31 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aileron-therapeutics-and-advancium-health-network-announce-an-exclusive-option-agreement-for-the-acquisition-of-alrn-6924-for-retinoblastoma-302292196.html
12 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aileron-therapeutics-to-present-previously-announced-data-from-the-phase-1b-clinical-trial-evaluating-low-dose-lti-03-in-idiopathic-pulmonary-fibrosis-ipf-at-the-22nd-international-colloquium-on-lung-and-airway-fibrosis-302274268.html
23 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aileron-therapeutics-completes-enrollment-in-cohort-2-of-the-ongoing-phase-1b-clinical-trial-evaluating-lti-03-in-idiopathic-pulmonary-fibrosis-ipf-302254831.html
14 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aileron-therapeutics-reports-second-quarter-2024-financial-results-and-business-highlights-302222882.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?